Paulo G. Kotze (@pakotze) 's Twitter Profile
Paulo G. Kotze

@pakotze

Life's a gas! Crohn's and Colitis my mission. Colorectal surgery unit - Catholic university of Parana.

ID: 164878826

linkhttp://lattes.cnpq.br/3666549932136698 calendar_today10-07-2010 00:36:06

17,17K Tweet

2,2K Followers

796 Following

Theo Pelly (@theohpelly) 's Twitter Profile Photo

🔍 New narrative review from Robin Phillips FRU, St Mark's explores the evolution of classification systems for perianal Crohn’s disease — including the Official TOpClass Consortium classification - and highlights key knowledge gaps. 📖 Read here: rdcu.be/enQcd Techniques in Coloproctology Journal #IBD #Crohns

Carl Kay, MD (@carlkaymd) 's Twitter Profile Photo

🚨 New ACG Crohn’s Guidelines (2025) ▪️Scope at 6–12 mo post-op ▪️Early advanced therapy = key ▪️Anti-TNF, IL-23, JAKi > mesalamine ▪️High-risk = smoking, prior surgery, penetrating dz ▪️Surgery for abscess >2cm or strictures 🔗 bit.ly/acg-crohns-2025

🚨 New ACG Crohn’s Guidelines (2025)

▪️Scope at 6–12 mo post-op
▪️Early advanced therapy = key
▪️Anti-TNF, IL-23, JAKi > mesalamine
▪️High-risk = smoking, prior surgery, penetrating dz
▪️Surgery for abscess >2cm or strictures

🔗 bit.ly/acg-crohns-2025
Robert Battat MD (@battatmd4ibd) 's Twitter Profile Photo

It was a pleasure to talk to Medscape about the importance of care of patients with #Crohns disease who need #surgery. medscape.com/viewarticle/ma…

Shicheng Guo (@shihchengguo) 's Twitter Profile Photo

IBD, initially a concern for North America, Europe, and Oceania, surged in Africa, Asia, and Latin America in the 21st century, evolving globally. PMID:40307548, Nature 2025, nature doi.org/10.1038/s41586… #AI #Pharma #BioMed #RNA #ASHG #ESHG

Dr Mark Silverberg (@guthealthmd) 's Twitter Profile Photo

Happy Canada Day! I am proud to be Canadian. Despite our flaws Canada is one of the greatest countries to live in and everyone here should be grateful for the privilege. I hope the values and tolerance that characterized Canada for most of my life - both from those born here as

Happy Canada Day! I am proud to be Canadian. Despite our flaws Canada is one of the greatest countries to live in and everyone here should be grateful for the privilege. I hope the values and tolerance that characterized Canada for most of my life - both from those born here as
Nicolas Avellaneda (@nlavellaneda) 's Twitter Profile Photo

Estuchando al 1 Fernando Gomollón en su clase introductoria del curso GADECCU para manejo clinico-quirurgico de EII en Cx Colorrectal Colaborativa LATAM . Clase verdaderamente magistral, supera ampliamente mis expectativas, que ya eran altas de por sí. Si no te inscribiste, todavia hay tiempo:

Estuchando al 1 <a href="/fgomollon/">Fernando Gomollón</a> en su clase introductoria del curso <a href="/gadeccu/">GADECCU</a> para manejo clinico-quirurgico de EII en <a href="/latamccr/">Cx Colorrectal Colaborativa LATAM</a> .

Clase verdaderamente magistral, supera ampliamente mis expectativas, que ya eran altas de por sí.

Si no te inscribiste, todavia hay tiempo:
Seb (@ibdseb) 's Twitter Profile Photo

Acute Severe Ulcerative Colitis: An International Delphi Consensus on Clinical Trial Design and Endpoints cghjournal.org/article/S1542-… Great to be a part of this work to progress one of the ‘orphan fields ‘ in #IBD We are using some of these concepts in the ACESO study in 🇬🇧

The Lancet Gastroenterology & Hepatology (@lancetgastrohep) 's Twitter Profile Photo

New The Lancet - Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3) thelancet.com/journals/lance… #GITwitter #MedTwitter

Remo Panaccione, MD, FRCPC (@rpanaccione) 's Twitter Profile Photo

GALAXI 2/3 just published in The Lancet . Guselkumab superior to placebo and ustekinumab across multiple endpoints in mod-dev CD. The rigor of the trial design highlights how IBD trials need to be done to move the field forward. Bruce E. Sands David T. Rubin, MD thelancet.com/journals/lance…

Jornal Nacional (@jornalnacional) 's Twitter Profile Photo

Médicos alertam para aumento dos casos de câncer colorretal entre pessoas com menos de 50 anos. Mais de 45 mil brasileiros devem receber o diagnóstico em 2025. É o 3º tipo de câncer mais comum entre mulheres e homens no país. Confira: glo.bo/3ICXWgx #JN

roypounder.apt (@apandt) 's Twitter Profile Photo

Patients with colon cancer and inflammatory bowel disease experience worse overall survival compared to colon cancer patients without inflammatory bowel disease, after adjustments for covariates. Read the full paper via bit.ly/4lUXo44 #GItwitter #coloncancer #IBD

Patients with colon cancer and inflammatory bowel disease experience worse overall survival compared to colon cancer patients without inflammatory bowel disease, after adjustments for covariates.  Read the full paper via bit.ly/4lUXo44
#GItwitter #coloncancer #IBD
roypounder.apt (@apandt) 's Twitter Profile Photo

"Appendectomy Is Not Associated With a Milder Clinical Course of Ulcerative Colitis: A Nationwide Danish Population-Based Study" - available to read 'open access' via bit.ly/416T6hL #GItwitter #ulcerativecolitis #IBD

"Appendectomy Is Not Associated With a Milder Clinical Course of Ulcerative Colitis: A Nationwide Danish Population-Based Study" - available to read 'open access' via bit.ly/416T6hL
#GItwitter #ulcerativecolitis #IBD
Shomron Ben-Horin (@shomronh) 's Twitter Profile Photo

A bombshell metaanalysis just landed in CGH : Advanced therpies work better in colonic #Crohn vs. Ileal dis 😱 aTNFs/aIL23-aIL12/23 were all more effective in the colon, aIntegrin same efficacy in both(?), and JAKi were ONLY EFFECTIVE IN COLON.... cghjournal.org/article/S1542-…